Mazoteras-Pardo, VictoriaBecerro-de-Bengoa-Vallejo, RicardoLosa Iglesias, Marta ElenaMartínez-Jiménez, Eva MaríaCalvo-Lobo, CésarRomero Morales, CarlosLópez-López, DanielPalomo-López, Patricia2020-09-162020-09-162020-07Mazoteras-Pardo V, Becerro-De-Bengoa-Vallejo R, Losa-Iglesias ME, Martínez-Jiménez EM, Calvo-Lobo C, Romero-Morales C, López-López D, Palomo-López P QardioArm Blood Pressure Monitoring in a Population With Type 2 Diabetes: Validation Study J Med Internet Res 2020;22(7):e19781 DOI: 10.2196/197811438-8871http://hdl.handle.net/2183/26195[Abstract] Background: Home blood pressure monitoring has many benefits, even more so, in populations prone to high blood pressure, such as persons with diabetes. Objective: The purpose of this research was to validate the QardioArm mobile device in a sample of individuals with noninsulin-dependent type 2 diabetes in accordance with the guidelines of the second International Protocol of the European Society of Hypertension. Methods: The sample consisted of 33 patients with type 2 diabetes. To evaluate the validity of QardioArm by comparing its data with that obtained with a digital sphygmomanometer (Omron M3 Intellisense), two nurses collected diastolic blood pressure, systolic blood pressure, and heart rate with both devices. Results: The analysis indicated that the test device QardioArm met all the validation requirements using a sample population with type 2 diabetes. Conclusions: This paper reports the first validation of QardioArm in a population of individuals with noninsulin-dependent type 2 diabetes. QardioArm for home monitoring of blood pressure and heart rate met the requirements of the second International Protocol of the European Society of Hypertension.engAtribución 4.0 Internacionalhttp://creativecommons.org/licenses/by/4.0/Blood pressureHypertensionType 2 diabetesMobile applicationsSoftware validationjournal articleopen access